Skip to main content
Log in

Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans

Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To conduct a retrospective evaluation of using dog as ananimal model to study the fraction of oral dose absorbed (F) of 43drugs in humans and to briefly discuss potential factors that mighthave contributed to the observed differences in absorption.

Methods. Mean human and dog absorption data obtained under fastedstate of 43 drugs with markedly different physicochemical andpharmacological properties and with mean F values ranging from 0.015 to1.0 were obtained from the literature. Correlation of F values betweenhumans and dogs was studied. Based on the same references, additionalF data for humans and rats were also obtained for 18 drugs.

Results. Among the 43 drugs studied, 22 drugs were virtuallycompletely absorbed in both dogs and humans. However, the overallcorrelation was relatively poor (r2 = 0.5123) as compared to the earlier ratvs. human study on 64 drugs (r2 = 0.975). Several drugs showed muchbetter absorption in dogs than in humans. Marked differences in thenonliner absorption profiles between the two species were found forsome drugs. Also, some drugs had much longer Tmax values andprolonged absorption in humans than in dogs that might be theoreticallypredicted. Data on 18 drugs further support great similarity in F betweenhumans and rats reported earlier from our laboratory.

Conclusions. Although dog has been commonly employed as ananimal model for studying oral absorption in drug discovery anddevelopment, the present study suggests that one may need to exercise cautionin the interpretation of data obtained. Exact reasons for the observedinterspecies differences in oral absorption remain to be explored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. W. L. Chiou, and A. Barve. Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm. Res. 15:1792-1795 (1998).

    Google Scholar 

  2. Physicians' Desk Reference, 51th edition, pp. 1187-1190, Medical Economics company, Montvale, NJ, 1997.

  3. L. F. Lacey, E. K. Hussey, and P. A. Fowler. Single dose pharmacokinetics of sumatriptan in healthy volunteers. Eur. J. Clin. Pharmacol. 47:543-548 (1995)

    Google Scholar 

  4. M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd ed., Marcel Dekker, Inc., New York and Basel, 1982

    Google Scholar 

  5. H. C. Krasny, P. D. Miranda, M. R. Blum, and G. B. Elion. Pharmacokinetics and bioavailability of acyclovir in the dog. J. Pharmacol. Exp. Ther. 216:281-288 (1981).

    Google Scholar 

  6. F. H. Hsu, T. Prueksaritanont, M. G. Lee, and W. L. Chiou. The phenomenon and cause of dose-dependent oral absorption of chlorothiazide in rats: Extrapolation to human data based on the body surface area concept. J. Pharmacokin. Biopharm. 15:369-383 (1987).

    Google Scholar 

  7. D. E. Reserarits and T. R. Bates. Apparent dose-dependent absorption of chlorothiazide in dogs. J. Pharmacokin. Biopharm. 7:463-470 (1979).

    Google Scholar 

  8. H. A. Ahr, M. Boberg, E. Brendel, H. P. Krause, and W. Steinke. Pharmacokinetics of miglitol: Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. Arneim.-Forsch. 47:734-745 (1997).

    Google Scholar 

  9. K. Balon, B. U. Riebesehl, and B. W. Muller. Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm. Res. 16:882-888 (1999).

    Google Scholar 

  10. Y. L. He, S. Murby, G. Warhurst, L. Gifford, D. Walker, J. Ayrton, R. Eastmond, and M. Rowland. Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides. J. Pharm. Sci. 87:626-633 (1998).

    Google Scholar 

  11. J. Dreyfuss, J. M. Shaw, and J. J. Ross. Absorption of the β-adrenergic-blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man: An unusual species difference. Xenobiotica 8:503-508 (1978)

    Google Scholar 

  12. L. Z. Benet. Pharmacokinetics/pharmacodynamics of furosemide in man: A review. J. Pharmacokin. Biopharm. 7:1-27 (1979)

    Google Scholar 

  13. J. McAinsh and B. F. Holmes. Pharmacokinetic studies with atenolol in the dog. Biopharm. Drug Dispos. 4:249-261 (1983).

    Google Scholar 

  14. T. R. Marten, G. R. Bourne, G. S. Miles, B. Shuker, H. D. Rankine, and V. N. Dutka. The metabolism of ICI 118,587, a partial agoinst of ?1-adrenoceptors, in mice, rats, rabbits, dogs, and humans. Drug Metab. Dispos 12:652-660 (1984)

    Google Scholar 

  15. U. Fagerholm, M. Johansson, and H. Lennernäs. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 13:1336-1342 (1996)

    Google Scholar 

  16. T. T. Kararli. Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 16:351-380 (1995).

    Google Scholar 

  17. J. B. Dressman. Comparison of canine and human gastrointestinal physiology. Pharm. Res. 3:123-131 (1986).

    Google Scholar 

  18. J. H. Lin. Species similarities and differences in pharmacokinetics. Drug. Metab. Dispos. 23:1008-1021 (1995).

    Google Scholar 

  19. T. Prueksaritanont and W. L. Chiou. Absorption of iothalamate after oral administration: A preliminary study in humans and interspecies differences. Biopharm. Drug Dispos. 8:99-101 (1987).

    Google Scholar 

  20. W. L. Chiou. New perspectives on the theory of permeability and resistance in the study of drug transport and absorption. J. Pharmacokin. Biopharm. 24:433-442 (1996).

    Google Scholar 

  21. J. A. Scatina, D. R. Hicks, M. Kraml, and M. N. Cayen. Metabolic disposition and pharmacokinetics of pelrinone, a new cardiotonic drug, in laboratory animals and man. Eur. J. Drug Metab. Pharmacokin. 15:37-48 (1990).

    Google Scholar 

  22. F. L. S. Tse. Pharmacokinetics in drug discovery and development. Chapter 12 in “Pharmacokinetics: Regulatory, Industrial, Academic Perspectives”, 2nd Ed., edited by P. G. Welling and F. L. S. Tse. Marcel Dekker, Inc., New York, NY, 1995.

    Google Scholar 

  23. E. H. Ulm. Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: Absorption, disposition and metabolism in man. Drug. Metab. Rev. 14:99-110 (1983).

    Google Scholar 

  24. D. I. Friedman and G. L. Amidon. Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: Enalapril and fosinopril. Pharm. Res. 6:1043-1047 (1989).

    Google Scholar 

  25. D. C. Garg, D. J. Weidler, and F. N. Eshelman. Ranitidine bioavailability and kinetics in normal male subjects. Clin. Pharmacol. Ther. 33:445-452 (1983).

    Google Scholar 

  26. P. J. Eddershaw, A. P. Chadwick, D. M. Higton, S. H. Fenwick, P. Linacre, W. N. Jenner, J. A. Bell, and G. R. Manchee. Absorption and disposition of ranitidine hydrochloride in rat and dog. Xenobiotica 26:947-956 (1996).

    Google Scholar 

  27. C. M. Dixon, D. A. Saynor, P. D. Andrew, J. Oxford, A. Bradbury, and M. H. Tarbit. Disposition of sumatriptan in laboratory animals and humans. Drug Metab. Dispos. 21:761-769 (1993).

    Google Scholar 

  28. J. D. Fitzgerald, R. Ruffin, K. G. Smedstad, R. Roberts, and J. McAinsh. Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. Eur. J. Clin. Pharmacol. 13:81-89 (1978).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiou, W.L., Jeong, H.Y., Chung, S.M. et al. Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans. Pharm Res 17, 135–140 (2000). https://doi.org/10.1023/A:1007552927404

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007552927404

Navigation